Home›Stock Screener›Denis Chem Lab

Denis Chem Lab Share Price Today | Stock Price & Denis Chem Lab Share Screener

DENISCHEM Pharmaceuticals
Live Share Price BSE
₹67.26
▼ -0.15 (-0.22%)
2026-10-05 00:00:00

As of October 5, 2026, the live Denis Chem Lab share price (BSE: DENISCHEM) is ₹67.26, down 0.22% from the previous close, with shares trading between ₹66.00 and ₹69.90 in today's trading session, and a 52-week range of ₹56.54–₹93.62. Check DENISCHEM 52-week chart for the annual price range and momentum. Use the Denis Chem Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Denis Chem Lab opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹185 and net income of ₹8, with EBITDA of ₹19, an operating margin of 9.0% and a profit margin of 4.3%.

Denis Chem Lab Market Cap ₹93.29 Cr.
DENISCHEM P/E Ratio (TTM) 11.72
Denis Chem Lab P/B Ratio 1.02
EPS (TTM) ₹6.06
Dividend Yield 3.71%
Debt to Equity 0.03
DENISCHEM 52 Week High ₹93.62
Denis Chem Lab 52 Week Low ₹56.54
Operating Margin 9.00%
Profit Margin 4.32%
DENISCHEM Revenue (TTM) ₹185.00
EBITDA ₹19.00
Net Income ₹8.00
Total Assets ₹125.00
Total Equity ₹92.00

Denis Chem Lab Share Price Chart

Track the current stock price of Denis Chem Lab with an interactive chart. Analyse DENISCHEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Denis Chem Lab stock quote in one place.

The quote of ₹67.26 sits between the 52-week low of ₹56.54 and the 52-week high of ₹93.62, and the latest session moved -0.22% from the previous close.

Denis Chem Lab Company Profile - Fundamental Screener

Screen Denis Chem Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DENISCHEM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE051G01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE051G01012

Denis Chem Lab Balance Sheet Screener

Screen DENISCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹125, up from ₹112 in 2025.

Latest statistics put total assets at ₹125 and shareholder funds at ₹92, with a leverage ratio of 0.03.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 125 112 109 99 96 92 97 106 101 94
Current Assets 85 71 69 59 53 49 50 54 53 48
Fixed Assets 37 39 38 35 42 41 46 50 40 44

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 1 2 3 5 6 4 6 11 20
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 92 85 80 72 67 62 59 57 50 30
Share Capital 14 14 14 14 14 14 14 14 14 12
Reserves & Surplus 78 71 67 58 53 48 45 43 36 18

Denis Chem Lab Income Statement Screener - Profit & Revenue Analysis

Screen Denis Chem Lab income statement and profit fundamentals. Analyze DENISCHEM quarterly results. Denis Chem Lab reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹185 and net profit was ₹8, equal to earnings per unit of ₹5.80, at an operating margin of 9%.

In that period expenses were ₹166, interest cost ₹1 and tax ₹3. The next period listed, 2026-March, shows revenue of ₹184 and net profit of ₹8.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 185 184 176 169 161 138 110 136 126 108 114 100 77
Expenses 166 164 157 147 142 122 99 121 110 95 100 91 68

Operating Costs and Margins

EBITDA 19 20 19 23 19 15 11 15 16 13 15 9 10
Operating Profit % 9.00% 10.00% 9.00% 13.00% 12.00% 11.00% 9.00% 11.00% 11.00% 11.00% 12.00% 9.00% 12.00%
Depreciation 7 7 7 7 8 6 6 7 6 6 7 6 4
Interest 1 1 1 1 1 1 2 3 3 5 6 7 5

Profit and Earnings

Profit Before Tax 11 12 11 15 11 9 3 6 6 2 2 -3 0
Tax 3 4 3 4 3 3 1 2 0 0 1 1 0
Net Profit 8 8 8 11 8 6 2 4 6 2 1 -4 0
EPS 5.80 6.06 5.82 8.04 5.66 4.51 1.63 3.03 4.58 1.69 1.07 -4.92 0.09

Denis Chem Lab Cash Flow Screener - Liquidity Fundamentals

Screen DENISCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹4.

Over the same period, investing activities used ₹5 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 4 12 18 16 17 8 13 8 11 7
Investing Activities -5 -8 -15 -11 -10 -1 -2 -2 -16 -1

Financing and Net Cash

Financing Activities 0 -4 -4 -4 -7 -6 -14 -5 1 0
Net Cash Flow 0 0 -1 1 0 1 -3 1 -4 5

Denis Chem Lab Shareholding Pattern Screener

See Denis Chem Lab shareholding pattern with promoter, FII, and DII holdings. Check Denis Chem Lab promoter holding and ownership changes for DENISCHEM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 38.98%, foreign institutions 0.01%, domestic institutions 0.00% and the public 28.93%, spread across 6,927 shareholders.

The shareholder count was 6,927 in 2026-Mar, compared with 6,811 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98% 38.98%

Institutional Investors

FII Holding 0.01% 0.01% 0.00% 0.01% 0.01% 0.01% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.93% 29.48% 27.41% 28.22% 28.90% 28.94% 26.94% 26.88%
Other Holding 32.09% 31.53% 33.61% 32.79% 32.12% 32.07% 34.08% 34.14%
Shareholder Count 6,927 6,811 7,218 7,227 7,304 7,102 4,834 6,021

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Denis Chem Lab. Denis Chem Lab dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.50 per unit for 2026-March, a yield of 3.71%, compared with ₹1.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.50, ₹1.50 and ₹2.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.50 3.71%
2025-March ₹1.50 2.65%
2024-March ₹2.50 2.70%
2023-March ₹2.00 1.33%
2022-March ₹1.50 2.36%
2021-March ₹0.75 1.10%
2020-March ₹0.00 0.00%
2019-March ₹1.00 3.37%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Denis Chem Lab Stock Index Membership - Nifty & Sensex

See which indices include Denis Chem Lab stock. Check DENISCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Denis Chem Lab is not part of any tracked indices.
Only major market indices are tracked in our system.

Denis Chem Lab Market Events Screener - Corporate Actions

Get Denis Chem Lab corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Denis Chem Lab stock events that may affect DENISCHEM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 25, 2026, with a record date of September 25, 2026.

It is followed by Dividend dated September 18, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-25 2026-09-25 Annual General Meeting NA -1.38%
2026-09-18 2026-09-18 Dividend ₹ 2.50 /share -6.45%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -2.88%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 4.29%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 0.29%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -3.12%
2025-09-26 2025-09-26 Annual General Meeting NA -2.69%
2025-09-19 2025-09-19 Dividend ₹ 1.50 /share -11.78%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -4.71%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 4.32%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -10.11%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -4.16%
2024-09-26 2024-09-26 Annual General Meeting NA -7.95%
2024-09-19 2024-09-20 Dividend ₹ 2.50 /share -9.03%
2023-09-22 2023-09-23 Dividend ₹ 2.00 /share 34.35%

Denis Chem Lab Competitors Screener - Peer Stocks Comparison

Screen DENISCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 427,010 35.84 61,674 12.69% 11,565 33.78
Divis Laboratories 244,125 84.36 11,067 13.95% 2,568 49.73
Torrent Pharmaceuticals 181,512 84.01 13,886 20.34% 2,138 41.48
Zydus Life Science 113,616 24.88 27,658 17.64% 5,026 46.18
Cipla 107,890 32.42 29,045 2.24% 3,870 32.87
Laurus Labs 106,517 98.56 6,868 22.01% 890 56.11
Mankind Pharma 102,394 50.48 14,636 14.85% 1,938 55.53
Dr Reddys Laboratories 100,412 31.47 35,059 3.90% 4,158 52.91
Aurobindo Pharma 96,370 25.97 34,145 5.56% 3,503 49.89
Lupin 91,961 16.71 29,039 26.75% 5,356 29.12

Denis Chem Lab Company Announcements - News & Reports Screener

Screen DENISCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 28, 2026.

The next most recent announcements are dated September 27, 2026 and September 27, 2026.

Date Update Actions
2026-09-28 Closure of Trading Window -
2026-09-27 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-27 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-27 Intimation Of Approval Of Shareholders For Appointments Of Secretarial Auditors At 45Th AGM Of The Company. -
2026-09-27 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-27 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-27 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-27 Proceedings Of 45Th Annual General Meeting -
2026-09-04 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-18 Announcement Under Regulation 30 (LODR) - Notice Of 45Th AGM Along With Annual Report 2025-26 -
2026-08-18 Shareholders Meeting - Submission Of Notice Of 45Th AGM Of The Company Along With Annual Report 2025-26 -
2026-08-18 Reg. 34 (1) Annual Report. -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Result-Financials Result For June 30Th 2026 -
2026-08-13 Board Meeting Outcome for For Submission Of Unaudited Financial Results For The Quarter Ended On 30Th June 2026 -
2026-08-06 Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 30Th June 2026. -
2026-08-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-01 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-31 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹67.26, within a 52-week range of ₹56.54 to ₹93.62. The P/E ratio is 11.72 and the P/B ratio is 1.02, with earnings per unit of ₹6.06. Market capitalisation stands at ₹93.29 Cr and the dividend yield is 3.71%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 7, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.